US2024011974A1PendingUtilityA1

Compositions and methods for molecular labeling

Assignee: BIO RAD LABORATORIES INCPriority: Feb 18, 2011Filed: Jul 26, 2023Published: Jan 11, 2024
Est. expiryFeb 18, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C12N 15/1075G01N 33/532C12Q 2521/10C12Q 1/6806G01N 33/53G01N 33/58G01N 2458/10G01N 33/5436C40B 50/08C12Q 1/6874C12Q 1/6804C12Q 2563/179C12Q 2565/30
89
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides barcode libraries and methods of making and using them including obtaining a plurality of nucleic acid constructs in which each construct comprises a unique N-mer and a functional N-mer and segregating the constructs into a fluid compartments such that each compartment contains one or more copies of a unique construct. The invention further provides methods for digital PCR and for use of barcode libraries in digital PCR.

Claims

exact text as granted — not AI-modified
1 - 31 . (canceled) 
     
     
         32 . A method for analyte detection, the method comprising the steps of:
 exposing oligonucleotide-linked binding agents to target molecules contained in a tissue sample;   binding the binding agents to the target molecules to form a plurality of complexes, wherein each individual complex of the plurality of complexes comprises one of the target molecules linked via one of the binding agents to a nucleic acid that includes a barcode sequence; and   identifying the target molecules by detecting the barcode sequence.   
     
     
         33 . The method of  claim 32 , wherein the target molecules are each a protein. 
     
     
         34 . The method of  claim 32 , wherein each binding agent is a protein. 
     
     
         35 . The method of  claim 32 , wherein prior to the identifying step, the method further comprises releasing each barcode sequence from its complex. 
     
     
         36 . The method of  claim 32 , wherein each binding agent is an antibody and each target molecule is an antigen. 
     
     
         37 . The method of  claim 32 , wherein the identifying step comprises amplifying the nucleic acids of the complexes. 
     
     
         38 . The method of  claim 32 , wherein said tissue sample comprises a plurality of different target molecules, and each target molecule is associated with a unique nucleic acid sequence of a binding agent. 
     
     
         39 . The method of  claim 32 , wherein the tissue sample comprises cells from a tissue biopsy.

Join the waitlist — get patent alerts

Track US2024011974A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.